# A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

> **NCT01323153** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 300 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** dalcetrapib
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01323153
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2019-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01323153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01323153, "A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01323153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*